These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12054367)

  • 1. Fatal overdosage with nefopam (Acupan).
    Tracqui A; Berthelon L; Ludes B
    J Anal Toxicol; 2002; 26(4):239-43. PubMed ID: 12054367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal nefopam overdose.
    Kerr DE; Fletcher AK
    Emerg Med J; 2010 May; 27(5):407-8. PubMed ID: 20360495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal nefopam overdose.
    Urwin SC; Smith HS
    Br J Anaesth; 1999 Sep; 83(3):501-2. PubMed ID: 10655934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nefopam pharmacokinetics in patients with end-stage renal disease.
    Mimoz O; Chauvet S; Grégoire N; Marchand S; Le Guern ME; Saleh A; Couet W; Debaene B; Levy RH
    Anesth Analg; 2010 Nov; 111(5):1146-53. PubMed ID: 20971961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of route of administration on the pharmacokinetic behavior of enantiomers of nefopam and desmethylnefopam.
    Chawla J; Le Guern ME; Alquier C; Kalhorn TF; Levy RH
    Ther Drug Monit; 2003 Apr; 25(2):203-10. PubMed ID: 12657915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nefopam Hydrochloride: A Fatal Overdose.
    Seetohul LN; De Paoli G; Drummond G; Maskell PD
    J Anal Toxicol; 2015; 39(6):486-9. PubMed ID: 25855761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The management of acute pain in ambulatory patients. The place of nefopam].
    Dacero JP
    Presse Med; 2004 Feb; 33(4):277-80. PubMed ID: 15029021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nefopam by continuous intravenous injection and adverse drug reactions: which causality assessment?].
    Ould-Ahmed M; Drouillard I; El-Kartouti A; Wey PF; Lions C; Martinez JY
    Ann Fr Anesth Reanim; 2007 Jan; 26(1):74-6. PubMed ID: 17158020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nefopam abuse.
    Villier C; Mallaret MP
    Ann Pharmacother; 2002 Oct; 36(10):1564-6. PubMed ID: 12243607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrin inclusion complexes of the central analgesic drug nefopam.
    Brun H; Paul M; Razzouq N; Binhas M; Gibaud S; Astier A
    Drug Dev Ind Pharm; 2006; 32(10):1123-34. PubMed ID: 17090434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics and pharmacodynamics of intravenous and oral nefopam in healthy volunteers.
    Aymard G; Warot D; Démolis P; Giudicelli JF; Lechat P; Le Guern ME; Alquier C; Diquet B
    Pharmacol Toxicol; 2003 Jun; 92(6):279-86. PubMed ID: 12787260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nefopam enantiomers: preclinical pharmacology/toxicology and pharmacokinetic characteristics in healthy subjects after intravenous administration.
    Mather GG; Labroo R; Le Guern ME; Lepage F; Gillardin JM; Levy RH
    Chirality; 2000 Mar; 12(3):153-9. PubMed ID: 10689295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of nefopam transdermal matrix patch system in human volunteers.
    De P; Damodharan N; Mallick S; Mukherjee B
    PDA J Pharm Sci Technol; 2009; 63(6):537-46. PubMed ID: 20169860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To enhance the efficiency of nefopam transdermal iontophoresis by using a novel method based on ion-exchange fiber.
    Xin C; Lihong W; Fei H; Yan W; Qifang W; Yang Y; Yue Y; San-ming L
    Drug Dev Ind Pharm; 2014 Jan; 40(1):9-16. PubMed ID: 23317337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of modulated electro-hyperthermia on the pharmacokinetic properties of nefopam in healthy volunteers: A randomised, single-dose, crossover open-label study.
    Lee SY; Kim MG
    Int J Hyperthermia; 2015; 31(8):869-74. PubMed ID: 26507458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of pharmacokinetics and comparative bioavailability of nefopam 30 mg tablets in twelve fasting healthy Pakistani male young subjects: single-dose, randomized, two-period, two-treatment and two-way cross-over design.
    Ahmad M; Yaqoob M; Murtaza G
    Med Princ Pract; 2012; 21(3):271-6. PubMed ID: 22123270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of nefopam in elderly, with or without renal impairment, and its link to treatment response.
    Djerada Z; Fournet-Fayard A; Gozalo C; Lelarge C; Lamiable D; Millart H; Malinovsky JM
    Br J Clin Pharmacol; 2014 Jun; 77(6):1027-38. PubMed ID: 24252055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal cyclobenzaprine overdose with postmortem values.
    Spiller HA; Cutino L
    J Forensic Sci; 2003 Jul; 48(4):883-4. PubMed ID: 12877312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effects of nefopam in patients undergoing bimaxillary osteotomy: A double-blind, randomized, placebo-controlled study.
    Park HJ; Park JU; Yoo W; Moon YE
    J Craniomaxillofac Surg; 2016 Feb; 44(2):210-4. PubMed ID: 26725583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compartmental pharmacokinetics of nefopam during mild hypothermia.
    Podranski T; Bouillon TW; Riva T; Kurz AM; Oehmke MJ
    Br J Anaesth; 2012 May; 108(5):784-91. PubMed ID: 22331396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.